Priority ranking of Chinese patent medicine prescriptions for type 2 diabetes mellitus (syndrome of deficiency of both Qi and Yin): based on analytic hierarchy process (AHP).
10.19540/j.cnki.cjcmm.20220106.502
- Author:
Jian FANG
1
;
Qing-Yu XIE
2
;
Qing-Gang MENG
1
;
Hong-Yu MENG
3
;
Xiang-Jia LUAN
4
Author Information
1. Beijing University of Chinese Medicine Beijing 100029, China.
2. Yinchuan Internet Hospital Yinchuan 750027, China.
3. Department of Renal Endocrinology, Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700, China.
4. Geriatrics Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China.
- Publication Type:Journal Article
- Keywords:
analytic hierarchy process(AHP);
case-based reasoning;
evidence;
prescription decision;
type 2 diabetes mellitus
- MeSH:
Analytic Hierarchy Process;
China;
Diabetes Mellitus, Type 2/drug therapy*;
Drug Prescriptions;
Humans;
Medicine, Chinese Traditional;
Nonprescription Drugs/therapeutic use*;
Qi;
Syndrome;
Yin Deficiency/drug therapy*
- From:
China Journal of Chinese Materia Medica
2022;47(8):2237-2243
- CountryChina
- Language:Chinese
-
Abstract:
Clinical expertise, patient preference, and the best evidence are the three elements of evidence-based medicine. Based on high-level and high-quality evidence, qualitative and quantitative analysis of the prescribing decisions of physicians is beneficial to improving clinical efficacy. A mature methodological system is available for the retrieval, analysis, summary, evaluation, and recommendation of the evidence, but there are still few studies on physicians' prescribing decisions. How to analyze the trend of physicians' prescribing decisions based on the priority ranking in addition and subtraction of prescriptions? Analytic hierarchy process(AHP) is a method for decision making, which arranges the elements of the decision problem into overall goal, criteria, and operational sub-criteria, and uses the matrix eigenvector method to solve the problem. This study aims to analyze the priority of physicians' prescribing decisions for diabetes mellitus with deficiency of both Qi and Yin based on AHP. To be specific, a database of diabetes mellitus cases with deficiency of both Qi and Yin was established and AHP was used to yield the priority ranking of Chinese patent medicine prescriptions in specific clinical scenarios. In the selected cases of diabetes mellitus with deficiency of both Qi and Yin, Xiaoke Pills was the best prescription for the treatment of type 2 diabetes mellitus(deficiency of both Qi and Yin)(normalized=0.388), followed by Liuwei Dihuang Pills(normalized=0.269), Qishen Capsules(normalized=0.230), and Shengmai Injection(normalized=0.113). According to the analysis the available data, for type 2 diabetes mellitus(deficiency of both Qi and Yin), Xiaoke Pills was the most effective prescription in specific scenarios. When the physicians' prescribing decisions are consistent with the evidence, quantitative analysis of physicians' cognition will boost the evidence-based medical decision-making. However, the research results are also affected by the quality of literature, evidence level and priority, which are thus have some limitations. It is recommended that further small data research based on individual cases be carried out to lay a evidence-based basis for the clinical decision-making of type 2 diabetes mellitus.
